Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Brendan L C Kinney"'
Autor:
Chrystal Paulos, Gregory B Lesinski, Zachary S Buchwald, Nabil F Saba, Vikash Kansal, Andre J Burnham, Brendan L C Kinney, Nicole C Schmitt
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 1 (2023)
Background Anti-PD-1 immune checkpoint blockade is approved for first-line treatment of recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), but few patients respond. Statin drugs (HMG-CoA reductase inhibitors) are associated with supe
Externí odkaz:
https://doaj.org/article/8c89bacdb70947e88cb21a0488441844
Autor:
Vikash Kansal, Brendan L. C. Kinney, Srijayaprakash Uppada, Nabil F. Saba, William A. Stokes, Zachary S. Buchwald, Nicole C. Schmitt
Publikováno v:
Cancer Medicine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::917e30b09ede29fb6bd0b355c4440e0d
https://doi.org/10.1002/cam4.6011
https://doi.org/10.1002/cam4.6011
Autor:
Vikash Kansal, Andre J Burnham, Brendan L C Kinney, Nabil F Saba, Chrystal Paulos, Gregory B Lesinski, Zachary S Buchwald, Nicole C Schmitt
Publikováno v:
Journal for ImmunoTherapy of Cancer. 11:e005940
BackgroundAnti-PD-1 immune checkpoint blockade is approved for first-line treatment of recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), but few patients respond. Statin drugs (HMG-CoA reductase inhibitors) are associated with super
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::443c8c7e5b7d7de5b4ee1c3b2303d0a3
https://doi.org/10.1136/jitc-2022-005940
https://doi.org/10.1136/jitc-2022-005940